Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$4,529,520
+$614,700 QoQ
Shares Held
18,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,378
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cohen Klingenstein LLC holds $217,553,450 across 9 Drug Manufacturers - General names. ABBV ranks #4 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
129,013 | $154,742,075 | |
| 2 | JNJ |
Johnson & Johnson
|
127,994 | $32,506,636 | |
| 3 | AMGN |
Amgen Inc
|
31,270 | $11,323,492 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
18,000 | $4,529,520 | |
| 5 | GSK |
GSK plc
|
79,398 | $4,162,043 | |
| 6 | PFE |
Pfizer Inc
|
169,014 | $4,069,857 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
47,559 | $2,740,349 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
20,700 | $2,615,238 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,529,520 | 18,000 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $3,914,820 | 18,000 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $4,112,820 | 18,000 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $4,167,720 | 18,000 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $3,341,160 | 18,000 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,771,360 | 18,000 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,198,600 | 18,000 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $9,972,740 | 50,500 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $8,661,760 | 50,500 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $9,196,050 | 50,500 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $7,825,985 | 50,500 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $7,527,530 | 50,500 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $6,803,865 | 50,500 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $8,048,185 | 50,500 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $8,161,305 | 50,500 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $6,777,605 | 50,500 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $7,734,580 | 50,500 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $8,186,555 | 50,500 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $6,837,700 | 50,500 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $5,447,435 | 50,500 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $5,688,320 | 50,500 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $5,465,110 | 50,500 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $5,411,075 | 50,500 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $4,423,295 | 50,500 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $4,958,090 | 50,500 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $3,847,595 | 50,500 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||